Steroid receptor coactivator 3 is a key modulator of regulatory T cell–mediated tumor evasion
Proceedings of the National Academy of Sciences · 2023
DOI: 10.1073/pnas.2221707120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Sang Jun Han und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Cellular Biology, Baylor College of Medicine, Houston, TX 77030. Hauptthemen laut MEDLINE: Breast Neoplasms, Mammary Neoplasms, Animal, Nuclear Receptor Coactivator 3. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Steroid receptor coactivator 3 (SRC-3) is most strongly expressed in regulatory T cells (Tregs) and B cells, suggesting that it plays an important role in the regulation of Treg function. Using an aggressive E0771 mouse breast cell line syngeneic immune-intact murine model, we observed that breast tumors were “permanently eradicated” in a genetically engineered tamoxifen-inducible Treg-cell-specific SRC-3 knockout (KO) female mouse that does not possess a systemic autoimmune pathological phenotype. A similar eradication of tumor was noted in a syngeneic model of prostate cancer. A subsequent injection of additional E0771 cancer cells into these mice showed continued resistance to tumor development without the need for tamoxifen induction to produce additional SRC-3 KO Tregs. SRC-3 KO Tregs were highly proliferative and preferentially infiltrated into breast tumors by activating the chemokine (C-C motif) ligand (Ccl) 19/Ccl21/chemokine (C-C motif) receptor (Ccr)7 signaling axis, generating antitumor immunity by enhancing the interferon-γ/C-X-C motif chemokine ligand (Cxcl) 9 signaling axis to facilitate the entrance and function of effector T cells and natural killer cells. SRC-3 KO Tregs also show a dominant effect by blocking the immune suppressive function of WT Tregs. Importantly, a single adoptive transfer of SRC-3 KO Tregs into wild-type E0771 tumor-bearing mice can completely abolish preestablished breast tumors by generating potent antitumor immunity with a durable effect that prevents tumor reoccurrence. Therefore, treatment with SRC-3-deleted Tregs represents an approach to completely block tumor growth and recurrence without the autoimmune side effects that typically accompany immune checkpoint modulators.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Cellular Biology, Baylor College of Medicine, Houston, TX 77030.
- Nuclear Receptor, Transcription and Chromatin Biology Program, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030.
- Department of Medicine, Baylor College of Medicine, Houston, TX 77030.
ORCID-Profile: Sang Jun Han, Yosef Gilad, Rainer B Lanz, Jianming Xu, Clifford C Dacso, David M Lonard, Bert W O'Malley
Förderung
- NICHD NIH HHS
- HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
Han, S. J., Jain, P., Gilad, Y., Xia, Y., Sung, N., Park, M. J., Dean, A. M., Lanz, R. B., Xu, J., Dacso, C. C., Lonard, D. M., & O'Malley, B. W. (2023). Steroid receptor coactivator 3 is a key modulator of regulatory T cell–mediated tumor evasion. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2221707120
Vancouver
Han SJ, Jain P, Gilad Y, Xia Y, Sung N, Park MJ, et al. Steroid receptor coactivator 3 is a key modulator of regulatory T cell–mediated tumor evasion. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2221707120
BibTeX
@article{Han2023,
author = {Han, Sang Jun and Jain, Prashi and Gilad, Yosef and Xia, Yan and Sung, Nuri and Park, Mi Jin and Dean, Adam M and Lanz, Rainer B and Xu, Jianming and Dacso, Clifford C and Lonard, David M and O'Malley, Bert W},
title = {Steroid receptor coactivator 3 is a key modulator of regulatory T cell–mediated tumor evasion},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
doi = {10.1073/pnas.2221707120}
}
EUVIMED